Author:
Lawson Karla A.,Anderson Kristen,Snyder Rachel M.,Simmons-Menchaca Marla,Atkinson Jeffrey,Sun Lu-Zhe,Bandyopadhyay Abhik,Knight Vernon,Gilbert Brian E.,Sanders Bob G.,Kline Kimberly
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Bandyopadhyay A, Lopez-Castillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun L-Z (2002) Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft. Cancer Res 62:4690
2. Bernacki RJ, Pera P, Gambacorta P, Brun Y, Greco WR (2000) In vitro antitumor activity of 9-nitro-camptothecin as a single agent and in combination with other antitumor drugs. Ann N Y Acad Sci 922:293
3. Carpentier A, Groves S, Simmons-Menchaca M, Turley J, Zhao B, Sanders BG, Kline K (1993) RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. Nutr Cancer 19:225
4. Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P (2001) Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP. Cancer Res 61:7148
5. Clarke R (1997) Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46:255
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献